Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Valcour

Showing results (91-100 of 184) with videos related to

Pageof 19
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2022
Immunological, Cognitive, and Psychiatric Outcomes After Initiating Efavirenz- and Dolutegravir-based Antiretroviral Therapy During Acute Human Immunodeficiency Virus InfectionPhillip Chan, Bohyung Yoon, Donn Colby, et al.
HIV Clinical Trials|November 29, 2007
Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090Scott R Evans, Tzu-Min Yeh, Ned Sacktor, et al.
Journal of Neurovirology|September 21, 2012
Neurocognitive impairment in patients randomized to second-line lopinavir/ritonavir-based antiretroviral therapy vs. lopinavir/ritonavir monotherapyTorsak Bunupuradah, Ploenchan Chetchotisakd, Supunnee Jirajariyavej, et al.
AIDS (London, England)|June 30, 2020
Monocyte and CD4+ T-cell antiviral and innate responses associated with HIV-1 inflammation and cognitive impairmentVishakha Sharma, Christopher Bryant, Maria Montero, et al.
AIDS (London, England)|November 8, 2016
Immediate initiation of cART is associated with lower levels of cerebrospinal fluid YKL-40, a marker of microglial activation, in HIV-1 infectionMichael J Peluso, Victor Valcour, Nittaya Phanuphak, et al.
Journal of Neurovirology|November 5, 2014
Impact of the HIV Tat C30C31S dicysteine substitution on neuropsychological function in patients with clade C diseaseRobert H Paul, John A Joska, Carol Woods, et al.
The Journal of Infectious Diseases|May 22, 2015
Absence of Cerebrospinal Fluid Signs of Neuronal Injury Before and After Immediate Antiretroviral Therapy in Acute HIV InfectionMichael J Peluso, Victor Valcour, Jintanat Ananworanich, et al.
International Journal of Medical Sciences|January 11, 2007
HIV DNA and dementia in treatment-naïve HIV-1-infected individuals in Bangkok, ThailandBruce Shiramizu, Silvia Ratto-Kim, Pasiri Sithinamsuwan, et al.
Journal of Parkinson'S Disease|July 4, 2025
Parkinson's disease associated with <i>LRRK2</i>-R1441C mutation: Characterization and comparison with other <i>LRRK2</i> mutationsRafi Hadad, Roy N Alcalay, Inna Senderova, et al.
The Journal of Infectious Diseases|November 19, 2025
Neuroaxonal Injury in Acute HIV Infection and Following Immediate Antiretroviral TherapyPhillip Chan, Carlo Sacdalan, Suteeraporn Pinyakorn, et al.
Pageof 19

Showing results (91-100 of 184) with videos related to

Sort By:
Pageof 19
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2022
Immunological, Cognitive, and Psychiatric Outcomes After Initiating Efavirenz- and Dolutegravir-based Antiretroviral Therapy During Acute Human Immunodeficiency Virus InfectionPhillip Chan, Bohyung Yoon, Donn Colby, et al.
HIV Clinical Trials|November 29, 2007
Selegiline transdermal system (STS) for HIV-associated cognitive impairment: open-label report of ACTG 5090Scott R Evans, Tzu-Min Yeh, Ned Sacktor, et al.
Journal of Neurovirology|September 21, 2012
Neurocognitive impairment in patients randomized to second-line lopinavir/ritonavir-based antiretroviral therapy vs. lopinavir/ritonavir monotherapyTorsak Bunupuradah, Ploenchan Chetchotisakd, Supunnee Jirajariyavej, et al.
AIDS (London, England)|June 30, 2020
Monocyte and CD4+ T-cell antiviral and innate responses associated with HIV-1 inflammation and cognitive impairmentVishakha Sharma, Christopher Bryant, Maria Montero, et al.
AIDS (London, England)|November 8, 2016
Immediate initiation of cART is associated with lower levels of cerebrospinal fluid YKL-40, a marker of microglial activation, in HIV-1 infectionMichael J Peluso, Victor Valcour, Nittaya Phanuphak, et al.
Journal of Neurovirology|November 5, 2014
Impact of the HIV Tat C30C31S dicysteine substitution on neuropsychological function in patients with clade C diseaseRobert H Paul, John A Joska, Carol Woods, et al.
The Journal of Infectious Diseases|May 22, 2015
Absence of Cerebrospinal Fluid Signs of Neuronal Injury Before and After Immediate Antiretroviral Therapy in Acute HIV InfectionMichael J Peluso, Victor Valcour, Jintanat Ananworanich, et al.
International Journal of Medical Sciences|January 11, 2007
HIV DNA and dementia in treatment-naïve HIV-1-infected individuals in Bangkok, ThailandBruce Shiramizu, Silvia Ratto-Kim, Pasiri Sithinamsuwan, et al.
Journal of Parkinson'S Disease|July 4, 2025
Parkinson's disease associated with <i>LRRK2</i>-R1441C mutation: Characterization and comparison with other <i>LRRK2</i> mutationsRafi Hadad, Roy N Alcalay, Inna Senderova, et al.
The Journal of Infectious Diseases|November 19, 2025
Neuroaxonal Injury in Acute HIV Infection and Following Immediate Antiretroviral TherapyPhillip Chan, Carlo Sacdalan, Suteeraporn Pinyakorn, et al.
Pageof 19